115 related articles for article (PubMed ID: 15380672)
21. Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
Milei J; Bolomo NJ; Marantz A
Medicina (B Aires); 1982; 42(4):409-14. PubMed ID: 15171023
[No Abstract] [Full Text] [Related]
22. The activities of tissue xanthine oxidase and adenosine deaminase and the levels of hydroxyproline and nitric oxide in rat hearts subjected to doxorubicin: protective effect of erdosteine.
Fadillioglu E; Yilmaz HR; Erdogan H; Sogut S
Toxicology; 2003 Sep; 191(2-3):153-8. PubMed ID: 12965118
[TBL] [Abstract][Full Text] [Related]
23. The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2.
d'Anglemont de Tassigny A; Berdeaux A; Souktani R; Henry P; Ghaleh B
Eur J Heart Fail; 2008 Jan; 10(1):39-46. PubMed ID: 18164246
[TBL] [Abstract][Full Text] [Related]
24. Oleuropein prevents doxorubicin-induced cardiomyopathy interfering with signaling molecules and cardiomyocyte metabolism.
Andreadou I; Mikros E; Ioannidis K; Sigala F; Naka K; Kostidis S; Farmakis D; Tenta R; Kavantzas N; Bibli SI; Gikas E; Skaltsounis L; Kremastinos DT; Iliodromitis EK
J Mol Cell Cardiol; 2014 Apr; 69():4-16. PubMed ID: 24486195
[TBL] [Abstract][Full Text] [Related]
25. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?
Oliveira PJ; Gonçalves L; Monteiro P; Providencia LA; Moreno AJ
Curr Vasc Pharmacol; 2005 Apr; 3(2):147-58. PubMed ID: 15853634
[TBL] [Abstract][Full Text] [Related]
26. Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.
van Almen GC; Swinnen M; Carai P; Verhesen W; Cleutjens JP; D'hooge J; Verheyen FK; Pinto YM; Schroen B; Carmeliet P; Heymans S
J Mol Cell Cardiol; 2011 Sep; 51(3):318-28. PubMed ID: 21624372
[TBL] [Abstract][Full Text] [Related]
27. Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity.
Wattanapitayakul SK; Chularojmontri L; Herunsalee A; Charuchongkolwongse S; Niumsakul S; Bauer JA
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):80-7. PubMed ID: 15667600
[TBL] [Abstract][Full Text] [Related]
28. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H
J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695
[TBL] [Abstract][Full Text] [Related]
29. Tumor necrosis factor receptor deficiency exacerbated Adriamycin-induced cardiomyocytes apoptosis: an insight into the Fas connection.
Lien YC; Lin SM; Nithipongvanitch R; Oberley TD; Noel T; Zhao Q; Daosukho C; St Clair DK
Mol Cancer Ther; 2006 Feb; 5(2):261-9. PubMed ID: 16505099
[TBL] [Abstract][Full Text] [Related]
30. Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure.
Okafor CC; Perreault-Micale C; Hajjar RJ; Lebeche D; Skiroman K; Jabbour G; Doye AA; Lee MX; Laste N; Gwathmey JK
BMC Physiol; 2003 Jul; 3():6. PubMed ID: 12873352
[TBL] [Abstract][Full Text] [Related]
31. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant and anti-apoptotic effects of onion (Allium cepa) extract on doxorubicin-induced cardiotoxicity in rats.
Alpsoy S; Aktas C; Uygur R; Topcu B; Kanter M; Erboga M; Karakaya O; Gedikbasi A
J Appl Toxicol; 2013 Mar; 33(3):202-8. PubMed ID: 21996788
[TBL] [Abstract][Full Text] [Related]
33. Testosterone Antagonizes Doxorubicin-Induced Senescence of Cardiomyocytes.
Altieri P; Barisione C; Lazzarini E; Garuti A; Bezante GP; Canepa M; Spallarossa P; Tocchetti CG; Bollini S; Brunelli C; Ameri P
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26746999
[TBL] [Abstract][Full Text] [Related]
34. Doxorubicin-induced expression of LOX-1 in H9c2 cardiac muscle cells and its role in apoptosis.
Spallarossa P; Fabbi P; Manca V; Garibaldi S; Ghigliotti G; Barisione C; Altieri P; Patrone F; Brunelli C; Barsotti A
Biochem Biophys Res Commun; 2005 Sep; 335(1):188-96. PubMed ID: 16055083
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts.
Chen PY; Hou CW; Shibu MA; Day CH; Pai P; Liu ZR; Lin TY; Viswanadha VP; Kuo CH; Huang CY
Environ Toxicol; 2017 Feb; 32(2):679-689. PubMed ID: 27087047
[TBL] [Abstract][Full Text] [Related]
36. Salidroside improves doxorubicin-induced cardiac dysfunction by suppression of excessive oxidative stress and cardiomyocyte apoptosis.
Wang XL; Wang X; Xiong LL; Zhu Y; Chen HL; Chen JX; Wang XX; Li RL; Guo ZY; Li P; Jiang W
J Cardiovasc Pharmacol; 2013 Dec; 62(6):512-23. PubMed ID: 24072175
[TBL] [Abstract][Full Text] [Related]
37. Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities.
Choi EH; Chang HJ; Cho JY; Chun HS
Food Chem Toxicol; 2007 Oct; 45(10):1873-81. PubMed ID: 17524543
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol Suppresses Apoptosis and Ion Channel Remodelling of HL-1 Cardiac Myocytes Expressing E334K cMyBPC.
Endo R; Bahrudin U; Notsu T; Tanno S; Onohara T; Yamaguchi S; Ikeda N; Surastri B; Nakayama Y; Ninomiya H; Shirayoshi Y; Inagaki Y; Yamamoto K; Yoshida A; Hisatome I
Drug Res (Stuttg); 2016 Mar; 66(3):126-9. PubMed ID: 26479129
[TBL] [Abstract][Full Text] [Related]
39. Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats.
Della Torre P; Podesta A; Pinciroli G; Iatropoulos MJ; Mazué G
Toxicol Pathol; 1996; 24(4):398-402. PubMed ID: 8864181
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart.
Schwarz ER; Kersting PH; Reffelmann T; Meven DA; Al-Dashti R; Skobel EC; Klosterhalfen B; Hanrath P
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):207-15. PubMed ID: 14506546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
